4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Damora Therapeutics, Inc. (DMRA) operates in the Biotechnology industry and is headquartered in Waltham, United States with about 7 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, DMRA reported $0M in revenue and ($210M) in net income.
Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($211M) | ($21M) | ($36M) | ($61M) |
| Net Income | ($210M) | ($21M) | ($38M) | ($62M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($31M) | ($202M) | ($3M) | ($3M) | ($3M) | — |
| Net Income | ($28M) | ($201M) | ($3M) | ($3M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $260M | $17M | $38M | $73M | — |
| Total Liabilities | $20M | $1M | $6M | $11M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DMRA viewer.
About TickerBase · Data methodology & sources